{"SPADE_UN_30756": {"Sequence Information": {"Peptide Name": "Di PGLa-H", "Sequence": "KIAKVALKALKIAKVALKAL", "Sequence Length": 20, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [{"uniprotId": "Q91826", "uniprotUrl": "http://www.uniprot.org/uniprot/Q91826", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}, {"uniprotId": "Q99134", "uniprotUrl": "http://www.uniprot.org/uniprot/Q99134", "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."}], "Literature": [{"Title": "PGLa-H tandem-repeat peptides active against multidrug resistant clinical bacterial isolates.", "Pubmed ID": "27889303", "Reference": "Biochim Biophys Acta. 2017;1859:228-237", "Author": "Roncević T, Gajski G, Ilic N, Goić-Barisić I, Tonkić M, Zoranić L, Simunić J, Benincasa M, Mijaković M, Tossi A, Juretic D", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/27889303"}, {"Title": "Glycine Substitution Reduces Antimicrobial Activity and Helical Stretch of diPGLa-H in Lipid Micelles.", "Pubmed ID": "28426232", "Reference": "J Phys Chem B. 2017;121:4817-4822", "Author": "Sani MA, Saenger C, Juretic D, Separovic F", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/28426232"}, {"Title": "Relating Molecular Dynamics Simulations to Functional Activity for Gly-Rich Membranolytic Helical Kiadin Peptides.", "Pubmed ID": "37242675", "Reference": "Pharmaceutics. 2023;15:1433", "Author": "Roncević T, Maleš M, Sonavane Y, Guida F, Pacor S, Tossi A, Zoranić L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/37242675"}], "Mass": 2090.72, "PI": 10.7, "Net Charge": 6, "Hydrophobicity": 1.0, "Frequent Amino Acids": "AKL", "Absent Amino Acids": "CDEFGHMNOPQRSTUWY", "Basic Residues": 6, "Acidic Residues": 0, "Hydrophobic Residues": 14, "Polar Residues": 6, "Positive Residues": 6, "Negative Residues": 0, "SPADE ID": "SPADE_UN_30756", "Similar Sequences": [{"SPADE_ID": "SPADE_N_02003", "Similarity": 1.0, "Sequence": "KIAKVALKAL"}, {"SPADE_ID": "SPADE_UN_30756", "Similarity": 1.0, "Sequence": "KIAKVALKALKIAKVALKAL"}, {"SPADE_ID": "SPADE_UN_24880", "Similarity": 1.0, "Sequence": "LKALCRILKKLCRI"}], "Hemolytic Activity": "Human erythrocytes:50% Hemolysis=270±30 µM,Human embryonic kidney HEK293 cells:CC50=>32 µg/ml", "Target Organism": "Escherichia coli ATCC 25922(MIC=1.5µM),Escherichia coli ATCC 25922(MBC=1.5µM),Escherichia coli(MIC=6µM),Escherichia coli(MBC=12µM),Klebsiella pneumoniae ATCC 13883(MIC=3µM),Klebsiella pneumoniae ATCC 13883(MBC=3µM),Klebsiella pneumoniae(MIC=12µM),Klebsiella pneumoniae(MBC=24µM),Acinetobacter baumannii ATCC 19606(MIC=1.5µM),Acinetobacter baumannii ATCC 19606(MBC=1.5-3µM),Acinetobacter baumannii(MIC=1.5-3µM),Acinetobacter baumannii(MBC=3µM),Pseudomonas aeruginosa ATCC 27853(MIC=6µM),Pseudomonas aeruginosa ATCC 27853(MBC=12µM),Pseudomonas aeruginosa(MIC=6µM),Pseudomonas aeruginosa(MBC=12µM),Staphylococcus aureus ATCC 29213(MIC=0.75µM),Staphylococcus aureus ATCC 29213(MBC=1.5µM),Staphylococcus aureus(MIC=1.5µM),Staphylococcus aureus(MBC=1.5µM),Escherichia coli ATCC 25922(MIC=2µg/ml),Klebsiella pneumoniae ATCC 700603(MIC=8µg/ml),Acinetobacter baumannii ATCC 19606(MIC=1µg/ml),Pseudomonas aeruginosa ATCC 27853(MIC=>32µg/ml),Staphylococcus aureus ATCC 43300(MIC=2µg/ml),Candida albicans ATCC 90028(MIC=>32µg/ml),Cryptococcus neoformans ATCC 208821(MIC=4µg/ml),Staphylococcus aureus ATCC 25923(MIC=0.75µM),Staphylococcus aureus ATCC 25923(MBC=1.5µM),Human chronic B cell leukemia MEC-1(IC50=9±3µM)"}}}